Search Results - "Smorodin, Eugeniy P"

Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer by Smorodin, Eugeniy P

“…Over the past decades, a large amount of data has been accumulated in various subfields of glycobiology. However, much clinically relevant data and many tools…”
Get full text

Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level： The follow-up study of gastrointestinal cancer patients by Smorodin, Eugeniy-P, Kurtenkov, Oleg-A, Sergeyev, Boris-L, Kodar, Kristel-E, Chuzmarov, Valentin-I, Afanasyev, Vladimir-P

“…AIM： To study the influence of tumor removal on the serum level of IgG antibodies to tumor-associated Thomsen-Friedenreich （TF）, Tn carbohydrate epitopes and…”
Get full text

SPECIFICITY OF SERUM ANTI-Adi IgG ANTIBODIES FROM PATIENTS WITH GASTROINTESTINAL CANCER by Smorodin, Eugeniy P., Kurtenkov, Oleg A., Sergeyev, Boris L., Branovets, Jelena S., Izotova, Jelena G., Formanovsky, Andrey A.

“…Changes in the glycosylation in cancer may lead to an aberrant expression of A, B incompatible or xenogeneic blood group related antigens. To characterize the…”
Get full text

Association of CD2 with Fibrinogen in Human Plasma: Depletion of the Soluble E-Receptor in Blood Clotting by Smorodin, Eugeniy P., Kurtenkov, O. A., Shevchuk, I. N.

“…The soluble E-receptor (SER) of lymphocytes that is related to CD2 was detected in human plasma and serum using immunoelectrophoresis with sheep antiserum. All…”
Get full text

SPECIFICITY OF SERUM ANTI-A di IgG ANTIBODIES FROM PATIENTS WITH GASTROINTESTINAL CANCER by Smorodin, Eugeniy P., Kurtenkov, Oleg A., Sergeyev, Boris L., Branovets, Jelena S., Izotova, Jelena G., Formanovsky, Andrey A.

Get full text

Specificity of serum anti-A(di) IgG antibodies from patients with gastrointestinal cancer by Smorodin, Eugeniy P, Kurtenkov, Oleg A, Sergeyev, Boris L, Branovets, Jelena S, Izotova, Jelena G, Formanovsky, Andrey A

“…Changes in the glycosylation in cancer may lead to an aberrant expression of A, B incompatible or xenogeneic blood group related antigens. To characterize the…”
Get full text